| 1 |
32276399 | Interferon Response in Hepatitis C Virus-Infected Hepatocytes: Issues to Consider in the Era of Direct-Acting Antivirals. | 2020 Apr 8 |
1 |
| 2 |
33127459 | Interferon lambda 4 gene polymorphisms as a predicting tool of response to hepatitis C virus genotype 4 patients treated with Sofosbuvir and Ribavirin. | 2020 Dec |
3 |
| 3 |
30027841 | Genetic Polymorphisms within Interferon-λ Region and Interferon-λ3 in the Human Pathophysiology: Their Contribution to Outcome, Treatment, and Prevention of Infections with Hepatotropic Viruses. | 2019 |
1 |
| 4 |
27027531 | IFNL4 polymorphism effects on outcome of simeprevir, peginterferon, and ribavirin therapy for older patients with genotype 1 chronic hepatitis C. | 2017 Mar |
1 |
| 5 |
27735085 | Impact of IFNL4 rs12979860 and rs8099917 polymorphisms on response to Peg-Interferon-α and Ribavirin in patients with congenital bleeding disorder and chronic hepatitis C. | 2017 Jul |
2 |
| 6 |
27180197 | Association between IFNL4 rs368234815 polymorphism and sustained virological response in chronic hepatitis C patients undergoing PEGylated interferon/ribavirin therapy: A meta-analysis. | 2016 Jul |
3 |
| 7 |
27904617 | The interferon lambda 4 rs368234815 predicts treatment response to pegylated-interferon alpha and ribavirin in hemophilic patients with chronic hepatitis C. | 2016 |
5 |
| 8 |
26032235 | The relationships between IFNL4 genotype, intrahepatic interferon-stimulated gene expression and interferon treatment response differs in HCV-1 compared with HCV-3. | 2015 Aug |
1 |
| 9 |
26186989 | Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance. | 2015 Nov |
1 |
| 10 |
24205831 | Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C. | 2014 Jan |
1 |
| 11 |
24355007 | Genetic polymorphism in IFNL4 and response to pegylated interferon-α and ribavirin in Japanese chronic hepatitis C patients. | 2014 Jan |
1 |
| 12 |
24362944 | Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C. | 2014 Dec |
1 |
| 13 |
24367041 | IFNL4-ΔG genotype is associated with slower viral clearance in hepatitis C, genotype-1 patients treated with sofosbuvir and ribavirin. | 2014 Jun 1 |
2 |
| 14 |
24415789 | Lymphocytes degranulation in liver in hepatitis C virus carriers is associated with IFNL4 polymorphisms and ALT levels. | 2014 Jun 15 |
1 |
| 15 |
24495847 | Nonsynonymous variant Pro70Ser (rs117648444) in IFNL4 gene identifies carriers of the rs368234815 ΔG allele with higher HCV RNA decline during the first 4 weeks of pegylated interferon and ribavirin therapy in HCV-1 patients. | 2014 Apr |
1 |
| 16 |
25548683 | IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including Regimens. | 2014 |
2 |
| 17 |
23939236 | Variation in IFNL4 genotype and response to interferon-based therapy of hepatitis C in HIV-positive patients with acute and chronic hepatitis C. | 2013 Nov 13 |
1 |